النهار أونلاين
النهار أونلاين
Ready to play
Ready to play
Pharma Invest, a company specializing in pharmaceutical manufacturing, signed a partnership agreement with the Chinese Yangtze River Pharmaceutical Group to enhance cooperation in transferring modern expertise and technology for controlling the production of raw pharmaceutical materials, as well as developing and producing innovative medicines. The goal is to support national technological and industrial capabilities and achieve healthcare sovereignty. During the meeting, steps were also outlined to establish a future agreement with Cidral regarding the production and distribution of high-value medicines, with the minister emphasizing the importance of these initiatives to strengthen the local pharmaceutical industry.
Notice: This Is an AI-Generated Summary
Comments (0)